Nick studied biomedical sciences at the University of Manchester, including one year at the Cancer Research UK Manchester Institute working on DNA damage and repair. He then ventured down south, completing a PhD at the Cancer Research UK London Research Institute on the signals that help cells move. He joined the News and Multimedia team in 2013, helping to manage the charity’s blog and news feed.
Category: Science blog June 15, 2016
From immunotherapy to targeted cancer treatment, here’s our round up of the big news from the annual ASCO conference.
The immune system’s natural killer cells, mobile phones and brain tumours, unhelpful fat recommendations and are rubbish dumps linked to lung cancer?
Category: Science blog May 21, 2016
Standardised cigarette packs; misleading talk of a ‘sunscreen gene’; waiting times missed in Wales and why preventing cancer isn’t ‘a walk in the park’.
Category: Science blog May 7, 2016
DNA study gives clearer picture of breast cancer, a robot does surgery, mobile phones and brain tumours plus why write a ‘universal cure’ headline?
Category: Science blog April 30, 2016
Report promotes switch to e-cigarettes, 30 years since Chernobyl, how the US might spend its cancer ‘moonshot’ money and can canned food cause cancer?
Category: Science blog April 23, 2016
More promising results for immunotherapy, aspirin analysis, long legs and cancer risk plus why has brushing your teeth been linked to pancreatic cancer?
Category: Science blog April 16, 2016
Rising womb cancer rates, gene editing tech could help make immune cells better, missed waiting time targets and do ‘good’ bacteria make a difference?
Category: Science blog April 14, 2016
Find out the details of the nine ideas that could answer one of our Grand Challenges in cancer prevention, diagnosis and treatment.
Category: Science blog March 19, 2016
A surprise sugar tax, tackling drug resistance with an HIV treatment, nanoparticles receive big hype and can artificial sweeteners cause cancer?
We explore the latest research from our scientists in Manchester that’s tracking how melanomas respond to treatment by analysing patient blood samples.